Research article · 1 Jan 2026
Conference abstractPublished 3 Jan 2018
Diagnosis and treatment in hepatology: The case of non-alcoholic fatty liver disease
University Magna GrÃ?¦cia of Catanzaro, Italy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Hepatic steatosis, a hallmark of non-alcoholic fatty liver diseases (NAFLD), is the hepatic manifestation of the metabolic syndrome and can vary from simple steatosis to cirrhosis and hepatocellular carcinoma. The pathogenesis of NAFLD is linked to a multiple-hit process. Although epidemiological data varies widely, it can be admitted that a realistic prevalence is around 30% of the general population. Its high prevalence in the general population and its many causes and complex mechanisms make it a pathology which must be treated and requires careful diagnosis also in terms of underlying causes, which may strongly vary among subjects. Non-invasive diagnostic methods should be able to reflect the presence and severity of liver fatty changes and the presence and severity of hepatic inflammation and fibrosis, since these are related to the risk of progression and clinical complications. The recent awareness of the commonness of NAFLD has prompted intensive research which unraveled many different mechanisms causing hepatic steatosis, from diet to intestinal diseases and liver receptors. Epigenetic factors must be added to this list. The variety of causes and mechanisms open many different potential therapeutic approaches. Performing randomized long-term clinical studies including liver biopsies appears as prerequisite to determine which treatment is the most valuable, however not ignoring that the therapeutic choice may require individualization among subjects as a function of the origins of NAFLD.
Subjects
Gastroenterology & HepatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Gastrointestinal & Digestive System.
Case report · 11 Nov 2025
Bitter Guard: A Gut Wrenching Surprise
Research article · 18 Jun 2025
Ursodeoxycholic Acid Treatment of LPAC Presenting as Post Cholecystectomy Pain: Rationale and Design of a Randomised Trial
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Gastrointestinal & Digestive System
- SubjectGastroenterology & Hepatology
- BylineArticles whose byline prints “Ludovico Abenavoli”